Physician profile
Andrew K Bailey
NPI 1285772160
$2,711.95
in general payments reported to CMS, 2019-2025
18 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $47.21 · 2021: $138 · 2022: $1,699 · 2023: $124 · 2024: $140 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nova Eye, INC. | $1,500.00 | 2022 | |
| Sight Sciences, INC. | $178.29 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ivantis, INC | $136.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $116.32 | 2019-2023 | |
| Alcon Vision LLC | $114.11 | 2022 | |
| Iridex Corporation | $106.78 | 2019 | |
| Merz Pharmaceuticals, LLC | $80.98 | 2023 | Xeomin |
| Aerie Pharmaceuticals, INC. | $80.93 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $58.70 | 2020-2022 | |
| Amgen INC. | $54.33 | 2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $53.19 | 2024 | Xdemvy |
| Abbvie INC. | $52.84 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.71 | 2019 | |
| Kala Pharmaceuticals, INC. | $31.78 | 2019-2021 | |
| Allergan, INC. | $31.58 | 2019-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $28.66 | 2020 | |
| New World Medical,INC. | $24.80 | 2023 | |
| Astellas Pharma US INC | $20.43 | 2024 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.